Nxera Pharma

(OTC) SOLTF

Current Price$6.19

Market Cap$571.87M

Since IPO (2014)-86%

5 Year-56%

1 Year-12%

1 Month-8%

Nxera Pharma Financials at a Glance

Market Cap

$571.87M

Revenue (TTM)

¥34.40B

Net Income (TTM)

-¥10.00B

EPS (TTM)

-$0.75

P/E Ratio

-8.41

Dividend

$0.00

Beta (Volatility)

0.06 (Low)

Dividend

$0.00

Beta (Volatility)

0.06 (Low)

Price

$6.19

Volume

900

Open

$6.19

Price

$6.19

Volume

900

Open

$6.19

Previous Close

$6.19

Daily Range

$6.19 - $6.19

52-Week Range

$4.90 - $7.94

Estimated Earnings Date

Aug 7, 2026

Dividend

$0.00

Beta (Volatility)

0.06 (Low)

Price

$6.19

Volume

900

Open

$6.19

Previous Close

$6.19

Daily Range

$6.19 - $6.19

52-Week Range

$4.90 - $7.94

Estimated Earnings Date

Aug 7, 2026

SOLTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nxera Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

382

CEO

Chris Cargill

Website

www.nxera.life

Headquarters

Tokyo, 102-0083, JP

SOLTF Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-7%

Net Income Margin

-29%

Return on Equity

-16%

Return on Capital

-2%

Return on Assets

-7%

Earnings Yield

-11.89%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$571.87M

Shares Outstanding

92.46M

Volume

900

Avg. Volume

1.67K

Financials (TTM)

Gross Profit

¥21.44B

Operating Income

-¥8.08B

EBITDA

-¥3.91B

Operating Cash Flow

-¥2.67B

Capital Expenditure

-¥448.39M

Free Cash Flow

-¥3.12B

Cash & ST Invst.

¥20.38B

Total Debt

¥57.38B

Nxera Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

¥11.33B

+70.5%

Gross Profit

¥10.20B

+102.9%

Gross Margin

90.07%

N/A

Market Cap

$571.87M

N/A

Market Cap/Employee

$1.48M

N/A

Employees

387

N/A

Net Income

¥1.80B

+337.4%

EBITDA

¥4.67B

+520.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

¥11.67B

-66.1%

Total Debt

¥56.18B

-15.2%

Accounts Receivable

¥14.15B

+217.2%

Inventory

¥11.23B

+28.1%

Long Term Debt

¥49.44B

-17.0%

Short Term Debt

¥6.74B

+0.8%

Return on Assets

-7.48%

N/A

Return on Invested Capital

-1.90%

N/A

Free Cash Flow

-¥1.97B

-490.9%

Operating Cash Flow

-¥1.66B

-371.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BPMUFBasilea Pharmaceutica AG

BPMUFBasilea Pharmaceutica AG$60.28+0.00%

VBIZFViva Biotech Holdings

VBIZFViva Biotech Holdings$0.13+0.00%

BOVNFBioInvent International AB (publ)

BOVNFBioInvent International AB (publ)$3.29+0.00%

GSGTFGenSight Biologics S.A.

GSGTFGenSight Biologics S.A.$0.09+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$185.00-0.04%

INTCIntel

INTCIntel$133.99+0.11%

NOKNokia

NOKNokia$13.49-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.99+0.04%

TAT&T

TAT&T$22.01-0.02%

NFLXNetflix

NFLXNetflix$77.38+0.01%

QSQuantumScape

QSQuantumScape$8.04+0.17%

Questions About SOLTF

What is the current price of Nxera Pharma?

Nxera Pharma is trading at $6.19 per share.

What is the 52-week range for Nxera Pharma?

Over the past 52 weeks, Nxera Pharma has traded between $4.90 and $7.94.

How much debt does Nxera Pharma have?

As of the most recent reporting period, Nxera Pharma reported total debt of ¥350.93M.

How much cash does Nxera Pharma have on hand?

Nxera Pharma reported ¥72.90M in cash and cash equivalents in its most recent financial results.

What is Nxera Pharma’s dividend yield?

Nxera Pharma does not currently have a dividend yield.

Nxera Pharma

Nxera Pharma Financials at a Glance

SOLTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nxera Pharma

SOLTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nxera Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SOLTF

What is the current price of Nxera Pharma?

What is the 52-week range for Nxera Pharma?

How much debt does Nxera Pharma have?

How much cash does Nxera Pharma have on hand?

What is Nxera Pharma’s dividend yield?

Premium Investing Services